LGR5 CAR-T cells: A novel potential treatment against high grade serous ovarian cancer.

被引：0
|
作者：
Wang, Wanqi [1 ]
Bandara, Veronika [1 ]
Lokman, Noor [1 ]
Napoli, Silvana [1 ]
Gundsambuu, Batjargal [1 ]
Oehler, Martin [2 ]
Barry, Simon C. [1 ]
Ricciardelli, Carmela [1 ]
机构：
[1] Univ Adelaide, Adelaide, SA, Australia
[2] Royal Adelaide Hosp, Adelaide, SA, Australia
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5183
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Molecular analysis of exceptional response in high-grade serous ovarian cancer.
    Garsed, Dale
    Pandey, Ahwan
    Fereday, Sian
    Alsop, Kathryn
    Wouters, Maartje
    Saner, Flurina
    Kennedy, Catherine
    Pearce, Celeste
    Pike, Malcolm
    Ramus, Susan
    Kobel, Martin
    deFazio, Anna
    Goode, Ellen
    Nelson, Brad
    Bowtell, David
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 17 - 18
  • [32] Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.
    Nath, Aritro
    Cosgrove, Patrick
    Copeland, Benjamin
    Mirsafian, Hoda
    Christie, Elizabeth
    Pflieger, Lance
    Majumdar, Sumana
    Cristea, Mihaela
    Han, Ernest
    Lee, Stephen
    Wang, Edward
    Fereday, Sian
    Traficante, Nadia
    Salgia, Ravi
    Werner, Theresa
    Cohen, Adam
    Moos, Phillip
    Chang, Jeffrey
    Bowtell, David
    Bild, Andrea
    CANCER RESEARCH, 2021, 81 (13)
  • [33] Genetic characterization of metastasis and prognosis in high-grade serous ovarian cancer.
    Kotnik, Emilee N.
    Spies, Nicholas C.
    Li, Tiandao
    Inkman, Matthew
    Zhang, Jin
    Martins-Rodrigues, Fernanda
    Hagemann, Ian S.
    McCourt, Carolyn K.
    Thaker, Premal H.
    Hagemann, Andrea R.
    Powell, Matthew A.
    Mutch, David G.
    Maher, Christopher A.
    Miller, Christopher A.
    Fuh, Katherine C.
    CANCER RESEARCH, 2021, 81 (13)
  • [34] Recurrent gene fusions are common in high-grade serous ovarian cancer.
    Lehtonen, Rainer
    Carpen, Olli
    Huhtinen, Kaisa
    Hynninen, Johanna
    Kaipio, Katja
    Lamminen, Tarja
    Cervera, Alejandra
    Hietanen, Sakari
    Grenman, Seija
    Hautaniemi, Sampsa
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 108 - 108
  • [35] Characterising phenotypically relevant intratumoural heterogeneity in high grade serous ovarian cancer.
    Fotopoulou, Christina
    Cunnea, Paula
    Rama, Nona R.
    Wulandari, Ratri
    Gorgy, Tommy
    Gabra, Hani
    Stronach, Euan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Mechanistic role of nelfinavir as drug-repurposing strategy against high-grade serous ovarian cancer.
    Subeha, Mahbuba R.
    Goyeneche, Alicia A.
    Telleria, Carlos M.
    CANCER RESEARCH, 2021, 81 (13)
  • [37] Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
    Guo, Jing
    Zeng, Xiaozhu
    Zhu, Yongjie
    Yang, Dong
    Zhao, Xudong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [38] 3D in vitro models uncover malignant cell intrinsic and extrinsic mechanisms of CAR-T cell resistance in high grade serous ovarian cancer
    Joy, Joash Dominic
    Malacrida, Beatrice
    Laforets, Florian
    Kotantaki, Panoraia
    Maniati, Eleni
    Hopkins, Sarah
    Garrobo-Calleja, Ianire
    Gautrot, Julien
    Balkwill, Frances
    CANCER RESEARCH, 2023, 83 (07)
  • [39] Combined MEK and BCL-2/XL inhibition as a potential drug combination for the treatment of high-grade serous ovarian cancer.
    Iavarone, Claudia
    Zervantonakis, Ioannis K.
    Selfors, Laura M.
    Palakurthi, Sangeetha S.
    Liu, Joyce F.
    Drapkin, Ronny
    Mills, Gordon B.
    Leverson, Joel D.
    Sampath, Deepak
    Matulonis, Ursula A.
    Brugge, Joan S.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 31 - +
  • [40] Novel strategies for targeting high-grade serous ovarian cancer
    Perets, Ruth
    Wyant, Gregory A.
    Ohman, Anders W.
    Setlur, Sunita R.
    Crum, Christopher P.
    Drapkin, Ronny
    Dinulescu, Daniela M.
    CLINICAL CANCER RESEARCH, 2015, 21
12345